NGVT Specialty Chemicals · Small cap · Transformation · Auto supplier · Thesis updated July 19, 2026

A cleaner Ingevity still has cleanup work

The core profit engine is Performance Materials, where Q1 2026 segment EBITDA margin reached 59.2%.
Hybrid vehicle demand is helping gasoline vapor control products while the EV shift remains a long-term risk.
Management sold road markings for $65 million and is still seeking a buyer or another option for APT.
APT sales rose 5% in Q1 2026, but its EBITDA margin fell to 17.2% on lower utilization.
The BASF case is over after a $113.2 million payment, but financial health still looks tight.

01 Running thesis

The smaller company is the bet

Ingevity is trying to become New Ingevity, a smaller and cleaner chemicals company built around two businesses: Performance Materials and Pavement Technologies. The bull case is that this plan makes the good parts easier to see. Performance Materials is already very profitable, and Q1 2026 got help from buyers choosing hybrid vehicles instead of battery electric vehicles.

The bear case is that the cleanup is not done. Advanced Polymer Technologies, or APT, is still for sale or under review. Its Q1 2026 EBITDA margin fell to 17.2%, which could hurt the price a buyer is willing to pay. The company also still has indirect costs left behind by businesses it sold.

The stock story now depends on execution more than a big new product cycle. Investors should watch for an APT sale agreement, proof that stranded costs are coming out, and whether hybrid demand can keep supporting the activated carbon business.

May 2026→Q1 2026 confirmed the New Ingevity plan is moving forward. Performance Materials benefited from hybrid vehicle demand, but APT margin compression kept the update mixed.

May 2026▲The 10-Q confirmed two cleanup wins: road markings was sold to PPG for $65 million, and the BASF litigation was settled and paid for $113.2 million.

Feb 2026▼The 2025 10-K shifted the story toward portfolio execution risk. Ingevity announced the New Ingevity plan, but also recorded large impairments tied to APT and road markings.

Nov 2025→The industrial specialties divestiture clarified the portfolio, while APT revenue pressure and Performance Chemicals margin pressure made the operating picture less clean.

Aug 2025▼APT weakened sharply, including a $183.8 million goodwill impairment. That raised the risk that one troubled segment could offset progress elsewhere.

May 2025▲Performance Chemicals restructuring showed progress. Management exited low-margin revenue while segment EBITDA improved, which supported the margin-improvement thesis.

Feb 2025→Ingevity moved from planning to active restructuring, including plant closures and exits from low-margin revenue. The plan promised savings, but execution risk rose.

Oct 2024→The initial thesis centered on a major Performance Chemicals repositioning. The upside was a leaner, less cyclical business, while the risk was that savings would not offset weak markets.

02 Business model

High-margin carbon, road additives, and exits

Ingevity makes money by selling specialty chemical products to industrial customers. Its most valuable business is Performance Materials, which sells hardwood-based activated carbon used in gasoline vapor control systems and filtration. In Q1 2026, this segment produced $155.4 million of sales and a 59.2% EBITDA margin.

Pavement Technologies sells additives and tools used in asphalt construction, preservation, and recycling. This business depends on road budgets, contractor activity, and adoption of products like warm mix asphalt. It is set to be one of the two core pieces of New Ingevity.

The model can break if the simplification plan stalls. Road markings was sold to PPG for $65 million after the quarter ended. APT remains the bigger open item. If that sale fails, or if leftover costs stay too high, the go-forward margin profile will look less clean than the bull case expects.

03 Product portfolio

What stays, what goes

Cash cow

Automotive activated carbon

This is the core Performance Materials product line. It helps control gasoline vapor emissions in internal combustion and hybrid vehicles, and it drove very high segment margins in Q1 2026.

Steady

Filtration activated carbon

Ingevity also sells activated carbon for food, water, and chemical filtration. It adds end-market variety, but the auto emissions use case remains the main focus of the thesis.

Steady

Pavement Technologies

This product line sells asphalt additives and road technologies for construction, preservation, and recycling. Q1 2026 sales were $49.7 million and it is a core part of New Ingevity.

Option

Road markings

This was part of Performance Chemicals, but it is no longer core. Ingevity completed the sale of the product line to PPG on April 15, 2026 for $65 million.

Option

Advanced Polymer Technologies

APT makes caprolactone-based polymers used in end markets like automotive, footwear, and industrial products. The whole segment remains under strategic review after weaker demand, competition, and lower plant utilization hurt results.

04 Business segments

Q1 2026 mix before the next sale

Performance Materials60%modest

Performance Chemicals23%flat

Advanced Polymer Technologies17%modest

Segment shares use Q1 2026 net sales from continuing operations: Performance Materials $155.4 million, Performance Chemicals $58.3 million, and APT $44.3 million. The mix will change if APT is sold, and road markings was sold after the quarter ended.

05 Risk factors

What could still go wrong

APT sale disappoints

High impact · Medium odds

APT is the largest remaining piece of the portfolio cleanup. Its Q1 2026 sales rose 5%, but EBITDA margin fell to 17.2% from 32.2% a year earlier. Lower plant utilization and competition could reduce the value of any deal, or leave Ingevity owning a weaker business longer than planned.

We watchA definitive APT sale agreement, sale price, buyer terms, and APT EBITDA margin in the next filings.

Stranded costs stay too high

High impact · Medium odds

Selling businesses does not remove every related cost on day one. Ingevity said the industrial specialties and road markings divestitures created $19 million to $21 million of indirect costs, and it expects to remove at least $15 million during 2026. If those savings lag, New Ingevity margins will look worse than promised.

We watchUpdates on indirect cost savings, especially the 2026 savings target and full run-rate savings in 2027.

EV shift cuts the carbon runway

High impact · Medium odds

Performance Materials depends on internal combustion and hybrid vehicles because its carbon products control gasoline vapors. Q1 2026 benefited from a consumer shift toward hybrids, but a faster move to battery electric vehicles would shrink the need for this product over time. The question is whether hybrids can be a long enough bridge.

We watchGlobal internal combustion and hybrid production, battery electric vehicle share, and Performance Materials sales growth.

Pavement demand slows

Medium impact · Medium odds

Pavement Technologies is a core part of New Ingevity, but it depends on road construction, preservation work, and government infrastructure budgets. Q1 2026 Pavement Technologies sales were about flat, with price and mix offset by lower volumes. A slowdown in public road spending would pressure the smaller company.

We watchPavement Technologies sales volume, infrastructure spending trends, and management commentary on warm mix asphalt adoption.

Balance sheet limits choices

Medium impact · Medium odds

The BASF litigation is now complete after a $113.2 million payment, which removes a major legal overhang. Still, Ingevity has had heavy restructuring, divestiture, and legal costs while also repurchasing shares. Weak financial health could limit how much room management has for buybacks, debt reduction, or new investments.

We watchNet debt, revolving credit capacity, cash flow from operations, and any updated capital allocation plan after the BASF payment.

06 Quick answers

In one breath

What does Ingevity actually make?

Ingevity makes specialty chemical products. Its key products include activated carbon for gasoline vapor control and filtration, asphalt additives for roads, and caprolactone-based polymers in APT.

Why is Ingevity selling businesses?

Management wants to create New Ingevity, a simpler company focused on higher-margin areas. It has sold industrial specialties and road markings, and APT remains under strategic review.

Why do hybrid cars matter for NGVT?

Hybrids still use gasoline engines, so they need vapor control systems that use Ingevity's activated carbon. That helps Performance Materials, even as fully electric vehicles remain a long-term risk.

What is the biggest near-term catalyst?

The biggest catalyst is a clear outcome for APT. A sale at a fair price would make the portfolio cleaner, while a weak deal or no deal would keep the main execution risk alive.